The impact of stent protrusion into the inferior vena cava or jailing of the contralateral iliac vein on the incidence of contralateral deep vein thrombosis following venous stenting

Abstract

Objective

Iliac vein stenting is the standard of care for patients with pelvic venous disorders secondary to symptomatic iliac vein outflow obstruction. Venous stents are often extended proximally into the inferior vena cava (IVC) which may result in partial or complete coverage of the contralateral iliac vein. The purpose of this investigation is to determine if extension of iliac vein stents into the IVC results in increased risk of contralateral deep venous thrombosis (DVT).

Methods

We retrospectively reviewed prospectively collected data from 409 patients who underwent iliac vein stenting at the Center for Vascular Medicine (CVM) from 2019 to 2020. Stent type, covered territories, initial and follow-up consults, ultrasound and operative reports were reviewed to assess for incidence of post-implantation DVT. Patients were stratified into three groups: Iliac vein stents which protruded into the IVC, stents that completely covered the orifice of the contralateral iliac vein and those with no stent protrusion into the IVC.

Results

Out of 409 patients, the average age was 53.96 ± 13.40 years with 94 males and 315 females. All stents placed were Venovo stents and all iliac vein lesions were non-thrombotic stenoses. The average follow-up period was 14.35 ± 10.09 months. The most common territories stented were the IVC-LCIV-LEIV (n = , 74%) and the IVC-RCIV-REIV (n = , 26%). Stent protrusion and distance into the IVC in millimeters (mm) was the following: Partial protrusion (n = 314, 77%, 27.6 ± 19.1), jailing of the contralateral iliac vein (n = 78, 19%, 45.9 ± 18.6), no protrusion (n = 16, 4%). The overall DVT rate post-implantation was 0.49% (n = 2). No DVTs ipsilateral to the index stent were identified and both DVTs were contralateral DVTs. A hypercoaguable disorder was reported in 6 patients (1.5%). There were no significant differences in prevalence of contralateral DVT between the three groups. (p = .35).

Conclusion

The rate of contralateral DVTs post iliac vein stenting with Nitonol based stents is extremely low. Partial or complete coverage of the contralateral iliac vein via stenting does not result in an increased incidence of contralateral DVT in the short-term. Longer follow up is needed to determine if contralateral DVTs occur after long-term implantation.

Keywords

Deep vein thrombosis iliac stenting

Get full access to this article

View all access options for this article.

References

Neglen

Darcey

Olivier

, et al. Bilateral stenting at the iliocaval confluence. J Vasc Surg 2010; 51(6): 1457–1466.

Neglen

. Stenting is the “Method-of-Choice” to treat iliofemoral venous outflow obstruction. J Endovasc Ther 2009; 16(4): 492.

Raju

Neglen

. Stents for chronic venous insufficiency: why, where, how and when--a review. J Miss State Med Assoc 2008; 49(7): 199–205.

Neglen

Hollis

Olivier

, et al. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007; 46(5): 979–990.

Neglen

. Chronic venous obstruction: diagnostic considerations and therapeutic role of percutaneous iliac stenting. Vascular 2007; 15(5): 273–280.

Pappas

Lakhanpal

Soto

, et al. Pregnancy after iliac vein stenting for pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord 2021.

Lakhanpal

Kennedy

Lakhanpal

, et al. Pelvic venous insufficiency secondary to iliac vein stenosis and ovarian vein reflux treated with iliac vein stenting alone. J Vasc Surg Venous Lymphat Disord 2021; 9(5): 1193–1198.

Larkin

Hovav

Dwight

, et al. Common iliac vein obstruction in a symptomatic population is associated with previous deep venous thrombosis, and with chronic pelvic pain in females. J Vasc Surg Venous Lymphat Disord 2020; 8(6): 961–969.

Santoshi

RKN

Lakhanpal

Satwah

, et al. Iliac vein stenosis is an underdiagnosed cause of pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord 2018; 6(2): 202–211.

10.

Knuttinen

Xie

Jani

, et al. Pelvic venous insufficiency: imaging diagnosis, treatment approaches, and therapeutic issues. AJR Am J Roentgenol 2015; 204(2): 448–458.

11.

Daugherty

Gillespie

. Venous angioplasty and stenting improve pelvic congestion syndrome caused by venous outflow obstruction. J Vasc Surg Venous Lymphat Disord 2015; 3(3): 283–289.

12.

Phillips

Deipolyi

Hesketh

, et al. Pelvic congestion syndrome: etiology of pain, diagnosis, and clinical management. J Vasc Interv Radiol 2014; 25(5): 725–733.

13.

Durham

Machan

. Pelvic congestion syndrome. Semin Intervent Radiol 2013; 30(4): 372–380.

14.

Chung

Huh

. Comparison of treatments for pelvic congestion syndrome. Tohoku J Exp Med 2003; 201(3): 131–138.

15.

Sulakvelidze

Lakhanpal

, et al. A practice audit of short-term outcomes of Wallstents versus Venovo stents for the treatment of nonthrombotic iliac vein outflow stenoses. J Vasc Surg Venous Lymphat Disord 2023; 11(2): 357–364.

16.

Duarte-Gamas

Rocha-Neves

Pereira-Neves

, et al. Contralateral deep vein thrombosis after stenting across the iliocaval confluence in chronic venous disease - a systematic review. Phlebology 2020; 35(4): 221–230.

17.

Tran

Lakhanpal

, et al. Type of anti-thrombotic therapy for venous stenting in patients with non-thrombotic iliac vein lesions does not influence the development of in-stent restenosis. Phlebology 2020; 35(10): 805–813.

18.

Calcagno

Sulakvelidze

Kennedy

, et al. Transabdominal ultrasound accurately identifies a significant iliac vein area-reducing lesion in patients with pelvic venous insufficiency. J Vasc Surg Venous Lymphat Disord 2023; 11(6): 1213–1218.

19.

Murphy

Johns

Varney

, et al. Deep venous thrombosis associated with caval extension of iliac stents. J Vasc Surg Venous Lymphat Disord 2017; 5(1): 8–17.

20.

Khairy

Neves

Hartung

, et al. Factors associated with contralateral deep venous thrombosis after iliocaval venous stenting. Eur J Vasc Endovasc Surg 2017; 54(6): 745–751.

21.

Rathore

Gloviczki

Bjarnason

. Open surgical removal of iliac vein Wallstents with excision of pseudointima obstructing the contralateral iliac vein. J Vasc Surg Venous Lymphat Disord 2016; 4(4): 525–529.

22.

Williams

Nicklas

Obi

, et al. Pathologic characteristics of human venous in-stent stenosis and stent occlusion. J Vasc Surg Venous Lymphat Disord 2023; 11(1): 109–118.

23.

Hoshino

Yokoi

. Angioscopic evaluation after venous stents. J Vasc Surg Venous Lymphat Disord 2023; 11(1): 136–142.

24.

Kang

Hurwitz

Exner

, et al. Angioscopy: direct visualization of chronic venous occlusion, May-Thurner syndrome, and other applications in phlebology. J Vasc Surg Venous Lymphat Disord 2019; 7(6): 870–881.

25.

Caliste

Clark

Doyle

, et al. The incidence of contralateral iliac venous thrombosis after stenting across the iliocaval confluence in patients with acute or chronic venous outflow obstruction. J Vasc Surg Venous Lymphat Disord 2014; 2(3): 253–259.

26.

Lee

Park

, et al. Contralateral deep vein thrombosis after iliac vein stent placement in patients with may-thurner syndrome. J Vasc Interv Radiol 2018; 29(6): 774–780.